"Our valuation for Kazia increases to US$294.2m or US$22.28 per basic ADR, from US$277m or US$20.92 per basic ADR, mainly due to rolling forward our NPV. This was partially offset by lower net cash at the end of H122 and higher R&D expectations. We have maintained the probability of success in BCBMs at 5% but will reassess this after expected data readouts in the coming months."
That's approx AU$3 per share.
"Our valuation for Kazia increases to US$294.2m or US$22.28 per...
-
- There are more pages in this discussion • 168 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)